High ATM nuclear expression in tumours showed an adverse clinical outcome with poor ovarian cancer specific survival (p = 0.01) (Fig. 2a) and progression free survival (p = 0.026) (Fig. 2b) compared with tumours that had low ATM expression. The gene discussed is ATM; the disease is ovarian cancer.